Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 24900867)

1.

Biarylmethoxy Nicotinamides As Novel and Specific Inhibitors of Mycobacterium tuberculosis.

Kedari CK, Roy Choudhury N, Sharma S, Kaur P, Guptha S, Panda M, Mukerjee K, Ramachandran V, Bandodkar B, Ramachandran S, Tantry SJ.

ACS Med Chem Lett. 2014 Mar 10;5(5):491-5. doi: 10.1021/ml4004815. eCollection 2014 May 8.

2.

2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis.

Naik M, Ghorpade S, Jena LK, Gorai G, Narayan A, Guptha S, Sharma S, Dinesh N, Kaur P, Nandishaiah R, Bhat J, Balakrishnan G, Humnabadkar V, Ramachandran V, Naviri LK, Khadtare P, Panda M, Iyer PS, Chatterji M.

ACS Med Chem Lett. 2014 Jul 11;5(9):1005-9. doi: 10.1021/ml5001933. eCollection 2014 Sep 11.

PMID:
25221657
3.

Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay.

Cai SX, Nguyen B, Jia S, Herich J, Guastella J, Reddy S, Tseng B, Drewe J, Kasibhatla S.

J Med Chem. 2003 Jun 5;46(12):2474-81.

PMID:
12773051
4.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
5.

Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.

P SH, Solapure S, Mukherjee K, Nandi V, Waterson D, Shandil R, Balganesh M, Sambandamurthy VK, Raichurkar AK, Deshpande A, Ghosh A, Awasthy D, Shanbhag G, Sheikh G, McMiken H, Puttur J, Reddy J, Werngren J, Read J, Kumar M, R M, Chinnapattu M, Madhavapeddi P, Manjrekar P, Basu R, Gaonkar S, Sharma S, Hoffner S, Humnabadkar V, Subbulakshmi V, Panduga V.

Antimicrob Agents Chemother. 2014;58(1):61-70. doi: 10.1128/AAC.01751-13. Epub 2013 Oct 14. Erratum in: Antimicrob Agents Chemother. 2014 Aug;58(8):4993-4.

6.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
7.

Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.

Pieroni M, Wan B, Cho S, Franzblau SG, Costantino G.

Eur J Med Chem. 2014 Jan 24;72:26-34. doi: 10.1016/j.ejmech.2013.11.007. Epub 2013 Nov 13.

PMID:
24333612
8.

Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.

Shakya N, Srivastav NC, Bhavanam S, Tse C, Desroches N, Agrawal B, Kunimoto DY, Kumar R.

Bioorg Med Chem. 2012 Jul 1;20(13):4088-97. doi: 10.1016/j.bmc.2012.05.004. Epub 2012 May 15.

PMID:
22664188
9.

Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors.

Jeankumar VU, Kotagiri S, Janupally R, Suryadevara P, Sridevi JP, Medishetti R, Kulkarni P, Yogeeswari P, Sriram D.

Bioorg Med Chem. 2015 Feb 1;23(3):588-601. doi: 10.1016/j.bmc.2014.12.001. Epub 2014 Dec 8.

PMID:
25541204
10.

Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents.

Shirude PS, Paul B, Roy Choudhury N, Kedari C, Bandodkar B, Ugarkar BG.

ACS Med Chem Lett. 2012 Aug 13;3(9):736-40. doi: 10.1021/ml300134b. eCollection 2012 Sep 13.

11.

Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay.

Guzman JD, Evangelopoulos D, Gupta A, Birchall K, Mwaigwisya S, Saxty B, McHugh TD, Gibbons S, Malkinson J, Bhakta S.

BMJ Open. 2013 Jun 20;3(6). pii: e002672. doi: 10.1136/bmjopen-2013-002672.

12.

Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening.

Kinjo T, Koseki Y, Kobayashi M, Yamada A, Morita K, Yamaguchi K, Tsurusawa R, Gulten G, Komatsu H, Sakamoto H, Sacchettini JC, Kitamura M, Aoki S.

J Chem Inf Model. 2013 May 24;53(5):1200-12. doi: 10.1021/ci300571n. Epub 2013 Apr 19.

PMID:
23600706
13.

A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.

Shen H, Wang F, Zhang Y, Huang Q, Xu S, Hu H, Yue J, Wang H.

FEBS J. 2009 Jan;276(1):144-54. doi: 10.1111/j.1742-4658.2008.06763.x. Epub 2008 Nov 20.

PMID:
19032598
14.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
15.

Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.

Koseki Y, Kinjo T, Kobayashi M, Aoki S.

Eur J Med Chem. 2013 Feb;60:333-9. doi: 10.1016/j.ejmech.2012.12.012. Epub 2012 Dec 20.

PMID:
23314046
16.

A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.

Knudson SE, Awasthi D, Kumar K, Carreau A, Goullieux L, Lagrange S, Vermet H, Ojima I, Slayden RA.

PLoS One. 2014 Apr 15;9(4):e93953. doi: 10.1371/journal.pone.0093953. eCollection 2014.

17.

Synthesis and anti-tubercular activity of 3-substituted benzo[b]thiophene-1,1-dioxides.

Chandrasekera NS, Bailey MA, Files M, Alling T, Florio SK, Ollinger J, Odingo JO, Parish T.

PeerJ. 2014 Oct 7;2:e612. doi: 10.7717/peerj.612. eCollection 2014.

18.

New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.

Anthony KG, Strych U, Yeung KR, Shoen CS, Perez O, Krause KL, Cynamon MH, Aristoff PA, Koski RA.

PLoS One. 2011;6(5):e20374. doi: 10.1371/journal.pone.0020374. Epub 2011 May 26.

19.

Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv).

Singla D, Tewari R, Kumar A, Raghava GP; Open Source Drug Discovery Consortium.

Chem Cent J. 2013 Mar 8;7(1):49. doi: 10.1186/1752-153X-7-49.

20.

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.

Singh S, Roy KK, Khan SR, Kashyap VK, Sharma A, Jaiswal S, Sharma SK, Krishnan MY, Chaturvedi V, Lal J, Sinha S, Gupta AD, Srivastava R, Saxena AK.

Bioorg Med Chem. 2015 Feb 15;23(4):742-52. doi: 10.1016/j.bmc.2014.12.060. Epub 2015 Jan 2.

PMID:
25614114
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk